UY Scuti Acquisition Corp.
NASDAQ:UYSCShell Companies
-$0.06 today
- Market cap
- $57.80M
- Beta
- 0.07
- P/E (TTM)
- 0.4
- EPS (TTM)
- $27.74
Volume 0.00M
Average 0.00M
UYSC EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
UY Scuti Acquisition Corp.NASDAQ: UYSC
EBITDA · Q3 FY2026 · quarter ended Dec 2025
EBITDA remains negative
Q3 FY2026 EBITDA was -$84.62K, compared with -$52.15K a year earlier. Trailing-twelve-month EBITDA was -$191.62K.
What to watch
Whether quarterly EBITDA holds near -$84.62K or moves back toward the trailing-twelve-month quarterly average of -$47.9K.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (156.52K) USD
- Year-over-year change
- -2219.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-03-31 | (156.52K) | -2219.5% |
| FY2024 | 2024-03-31 | (6.75K) | — |
EBITDA vs competitors
How UYSC compares with its peers on the latest reported figures
- UYSC's LTM Dec 2025 EBITDA of -$191.62K is the 3rd highest of the 6 companies compared; the peer median is -$288.56K.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
FVNFuture Vision II Acquisition Corp. | LTM Mar 2026 | $457.01K | +539.6% | — | — |
| LTM Mar 2026 | -$25.82K | +94.0% | — | — | |
UYSCUY Scuti Acquisition Corp. | LTM Dec 2025 | -$191.62K | — | — | — |
COLAColumbus Acquisition Corp | LTM Mar 2026 | -$288.56K | +11.2% | — | — |
| LTM Mar 2026 | -$466.32K | — | — | — | |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | -$484.33K | -135.0% | — | — |
| Peer median (excluding UYSC) | -$288.56K | +52.6% | — | — | |
Competitors are the stored peer set for UYSC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2024 Mar 2024 | FY2025 Mar 2025 |
|---|---|---|
| Revenue | 0 | 0 |
| Cost of Revenue | 0 | 0 |
| Gross Profit | 0 | 0 |
| Gross Margin | — | — |
| Research & Development | 0 | 0 |
| Selling, General & Admin | 6.75K | 156.52K |
| Operating Expenses | 6.75K | 156.52K |
| Depreciation & Amortization | 0 | 0 |
| EBITDA | (6.75K) | (156.52K) |
| EBITDA Margin | — | — |
| Operating Income | (6.75K) | (156.52K) |
| Operating Margin | — | — |
| Interest Income | 0 | 0 |
| Interest Expense | 0 | 0 |
| Other Income / Expenses | 0 | 0 |
| Income Before Tax | (6.75K) | (156.52K) |
| Pre-Tax Margin | — | — |
| Income Tax Expense | 0 | 0 |
| Net Income | (6.75K) | (156.52K) |
| Net Margin | — | — |
| EPS (Basic) | (0.01) | (0.11) |
| EPS (Diluted) | (0.01) | (0.11) |
| Weighted Avg Shares | 1.25K | 1.25K |
| Weighted Avg Shares (Diluted) | 1.25K | 1.25K |
UY Scuti Acquisition Corp.
NASDAQ:UYSC
Intrinsic Alpha fair value
Locked
Current Price
$11.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.